Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An immunomodulator is a substance that modifies the immune system's activity, either by stimulating or suppressing immune responses. These agents encompass a wide range of molecules, including small molecules, biologics like monoclonal antibodies, cytokines, and hormones. They are used to treat conditions where the immune system is either underactive or overactive, such as autoimmune diseases, cancer, and organ transplantation. Immunomodulators act by affecting the number and function of immune cells, modulating signaling pathways, and targeting specific molecules like cytokines, immune checkpoint proteins, and cell surface antigens.
Varies depending on the specific immunomodulator; includes immunostimulation, immunosuppression, modulation of cytokine production, modulation of immune cell activity, and interference with signaling pathways like NF-κB.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunomodulator.